{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 407198225
| IUPAC_name = (1''R'',2''S'',8''S'',10''S'',11''S'',13''R'',14''R'',15''S'',17''S'')-1,8-difluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0<sup>2,7</sup>.0<sup>11,15</sup>]heptadeca-3,6-dien-5-one
| image = Flumetasone.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CONS|flumethasone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_UK = <!-- GSL         / P       / POM / CD -->
| legal_US = <!-- OTC                   / Rx-only  -->
| legal_status =  
| routes_of_administration = Topical

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism = [[Liver|Hepatic]], [[CYP3A4]]-mediated
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 2135-17-3
| ATC_prefix = D07
| ATC_suffix = AB03
| ATC_supplemental = , {{ATC|D07|XB01}} (combinations), {{ATCvet|H02|AB90}}
| PubChem = 16490
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = LR3CD8SX89
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04208
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201392
| synonyms = Flumethasone ([[United States Adopted Name|USAN]])
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 15632
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 34764

<!--Chemical data-->
| C=22 | H=28 | F=2 | O=5 
| molecular_weight = 410.452 g/mol
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = WXURHACBFYSXBI-GQKYHHCASA-N
| smiles = C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)F
}}

'''Flumetasone''' ([[International Nonproprietary Name|INN]]), also known as '''flumethasone''' ([[United States Adopted Name|USAN]]),<ref>{{cite book|last1=Morton|first1=IK|last2=Hall|first2=JM|title=Concise Dictionary of Pharmacological Agents Properties and Synonyms|date=1999|publisher=Springer Netherlands|location=Dordrecht|isbn=9789401144391|page=122}}</ref> is a [[corticosteroid]] for topical use. Trade names include '''Locacorten''', '''Locorten''', and '''Orsalin'''.  It is available in combination with [[clioquinol]], under the trade name '''Locacorten-Vioform''' (in some countries Locorten-Vioform),  for the treatment of [[otitis externa]] and [[otomycosis]].  It is usually formulated as the [[pivalic acid]] [[ester]] [[prodrug]] '''flumetasone pivalate'''.

Flumethasone is 420 times as potent as cortisone in an animal model for anti-inflammatory activity.{{cn|date=September 2015}}

==See also==
* [[Glucocorticoid]]
* [[Corticosteroid]]
* [[Triamcinolone acetonide]]

==References==
{{Reflist|2}}


{{Glucocorticoids}}
{{Glucocorticoidics}}

[[Category:Glucocorticoids]]
[[Category:Organofluorides]]


{{dermatologic-drug-stub}}